RE:Market CapIs it possible that this company simply won't be assigned credibility while on this questionable exchange, end of story? I know the FDA itself can change that, of course, but it does make me wonder if a buyout or major partnership is the only way out of this predicament. My assumption is that getting to a better exchange would probably take multiple years, and a lot of execution and delivery first, which circles back to my question. Just thinking out loud, really.